Publication | Open Access

Reduced plaque size and inflammation in the APP23 mouse model for Alzheimer’s disease after chronic application of polymeric nanoparticles for CNS targeted zinc delivery

NanoparticlesNeurodegenerative DiseasesAlzheimer's DiseaseEngineeringPolymeric NanoparticlesMedicinePharmaceutical NanotechnologyNano-drug DeliveryNeurologyBiomedical EngineeringPlaque SizeNeuroimmunologyProtein NanoparticlesApp23 Mouse Model